Advanced search
News (307)
Companies (1)
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
Insiders
Mikael Dolsten holds the position of Chief Scientific Officer & Research President at Pfizer Inc. Dr. Dolsten is also on the board of New York Academy of Sciences, Karyopharm Therapeutics, Inc. and PhRMA Foundation and Member of Royal Swedish Academy of Engineering Sciences and Member of Government-University-Industry Research Roundtable. In the past he occupied the position of Principal at OrbiMed Advisors LLC and Partner at OrbiMed Advisors Private Equity (a subsidiary of OrbiMed Advisors LLC), President for Wyeth Research, EVP, Global Head-Pharma Research & Discovery at Boehringer Ingelheim Pharmaceuticals, Inc., Senior Vice President for Wyeth Corp. and Member-Benefits, Law & Regulatory Committee at Wyeth Pharmaceuticals LLC. Dr. Dolsten received a doctorate from the University of Lund.
Mikael Venø Munksgaard is currently working as Vice President & Portfolio Manager Corporate Bonds at Jyske Bank A since 2006.
Prior to this, he worked as Vice President & Portfolio Manager at Jyske Invest Fund Management A.
Mr. Mikael H.
Lorsell is a Portfolio Manager at Alcur Fonder AB.
Mr. Lorsell was previously employed as an Analyst by Danske Bank A/S (Sweden), a Research Analyst by Erik Penser Bank AB, and a Research Analyst by Swedbank AB (Broker).
He has a bachelor's degree in economics from Stockholm University.
Mikael Bo Larsen is currently working as a Senior Investor Relations Officer at Alm.
Brand A, as well as the Head of Information & Technology at Thyregod Bygningsindustri A, and the Head of Investor Relations at TORM Plc.
In the past, he has worked as the Director of Investor Relations at Carlsberg A and Carlsberg Breweries A.
Mikael Bartroff is a Director of Mitra Medical AB.
No results for this search
- Stock Market
- Advanced search
- Mikael Dolsten